Company news
Optiscan Imaging Limited (ASX:OIL) news
Optiscan Imaging Limited news releases on 6ix. Latest, Aug 15, 2023: Optiscan Achieves Telepathology Milestone
Press releases — page 2
Optiscan Achieves Telepathology Milestone
August 14, 2023
OIL June 2023 Quarterly Report and Appendix 4C
July 28, 2023
Entitlement Offer Results and Shortfall Announcement
July 12, 2023
Optiscan Launches Entitlement Offer to Raise $16.7M
May 30, 2023
Optiscan Entitlement Issue Prospectus
May 30, 2023
Trading Halt
May 25, 2023
OIL March 2023 Quarterly Report and Appendix 4C
April 28, 2023
Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
March 13, 2023
Optiscan Intends to pursue De Novo Pathway for InVivage
March 2, 2023
OIL Appendix 4D and 31 December 2022 Half-year report
February 27, 2023
Optiscan partners with Prolucid to develop AI Algorithms
January 29, 2023
OIL December 2022 Quarterly Report and Appendix 4C
January 27, 2023
Optiscan Managing Director 2022 AGM Presentation
November 24, 2022
OIL September 2022 Quarterly Report and Appendix 4C
October 31, 2022
Optiscan Imaging Acquires Intellectual Property
October 24, 2022
Appendix 4E and 2022 Annual Report
August 31, 2022
Optiscan Submits FDA 510(k) Application for InVivage Device
August 21, 2022
OIL June 2022 Quarterly Report and Appendix 4C
July 29, 2022
Strategic Distribution Partnership - Additional Information
June 28, 2022
Optiscan announces Strategic Distribution Partner for China
June 26, 2022
OIL March 2022 Quarterly Report and Appendix 4C
April 29, 2022
Appendix 4D and 31 December 2021 Half-year report
February 24, 2022
OIL December 2021 Quarterly Report and Appendix 4C
January 31, 2022
2021 AGM Chairmans Address and MD Presentation
January 20, 2022
Optiscan Imaging : Appointment of Prof. Camile Farah as New CEO & Managing Director
January 16, 2022
Change of Managing Director
December 12, 2021
Completion of imaging for Melbourne Breast cancer trial
November 11, 2021
OIL September 2021 Quarterly Report and Appendix 4C
October 26, 2021
Receipt of R&D Tax Incentive Rebate
October 25, 2021
OIL FY21 Annual Results Presentation
August 30, 2021
Appendix 4E and 2021 Annual Report
August 30, 2021
OIL June 2021 Quarterly Report and Appendix 4C
July 29, 2021
Update on seeking United States FDA approval & market entry
May 31, 2021
Optiscan Imaging : APPOINTMENT OF NEW NON-EXECUTIVE DIRECTOR
May 6, 2021
OIL March 2021 Quarterly Report and Appendix 4C
April 28, 2021
Optiscan Imaging : APPOINTMENT OF NEW NON-EXECUTIVE CHAIR
April 19, 2021
Appointment of New Non-executive Chair
April 18, 2021
Appendix 4D and Financial Statements - 31 December 2020
February 25, 2021
OIL breast cancer study to commence next stage - revised
February 8, 2021
Optiscan breast cancer study to commence next stage
February 8, 2021
OIL December 2020 Quarterly Report and Appendix 4C
January 28, 2021
Carl Zeiss Meditec AG Product Orders
January 12, 2021
Appointment of Taiwan Distributor
December 15, 2020
OIL 2020 AGM Presentation
November 26, 2020
TGA Approval for CONVIVO and Sterile Sheath In Australia
November 9, 2020
OIL September 2020 Quarterly Report and Appendix 4C
October 29, 2020
US FDA Regulatory Approval update
October 8, 2020
OptiScan Capital Raising
September 24, 2020
Optiscan Capital Raising
September 21, 2020
Pause in Trading
September 21, 2020